Small ubiquitin-like modifier 1 mediates the resistance of prosthesis-loosening fibroblast-like synoviocytes against Fas-induced apoptosis.

Meinecke I, Pap G, Mendoza H, Drange S, Ender S, Strietholt S, Gay RE, Seyfert C, Ink B, Gay S, Pap T, Peters MA

Research article (journal) | Peer reviewed

Abstract

OBJECTIVE: To study the expression of small ubiquitin-like modifier 1 (SUMO-1) in aseptic loosening of prosthesis implants and to investigate its role in regulating the susceptibility of prosthesis-loosening fibroblast-like synoviocytes (FLS) to Fas-induced apoptosis. METHODS: Specimens of aseptically loosened tissue were obtained at revision surgery, and the expression of SUMO-1 was analyzed by in situ hybridization. SUMO-1 levels in FLS were determined by quantitative polymerase chain reaction and Western blot analysis. Immunohistochemistry and confocal microscopy were used to study the subcellular localization of SUMO-1. The functional role of SUMO-1 in Fas-induced apoptosis of prosthesis-loosening FLS was investigated by small interfering RNA-mediated knockdown of SUMO-1 and by gene transfer of the nuclear SUMO-specific protease SENP1. RESULTS: SUMO-1 was expressed strongly in aseptically loosened tissue and was found prominently at sites adjacent to bone. Prosthesis-loosening FLS expressed levels of SUMO-1 similar to the levels expressed by rheumatoid arthritis (RA) FLS, with SUMO-1 being found mainly in promyelocytic leukemia protein nuclear bodies. Knockdown of SUMO-1 had no effect on spontaneous apoptosis but significantly increased the susceptibility of prosthesis-loosening FLS to Fas-induced apoptosis. Gene transfer of the nuclear SUMO-specific protease SENP1 reverted the apoptosis-inhibiting effects of SUMO-1. CONCLUSION: These data suggest that SUMO-1 is involved in the activation of both RA FLS and prosthesis-loosening FLS by preventing these cells from undergoing apoptosis. Modification of nuclear proteins by SUMO-1 contributes to the antiapoptotic effects of SUMO-1 in prosthesis-loosening FLS, providing evidence for the specific activation of sumoylation during their differentiation. Therefore, SUMO-1 may be an interesting target for novel strategies to prevent aseptic prosthesis loosening.

Details about the publication

JournalArthritis and Rheumatism (Arthritis Rheum)
Volume60
Issue7
Page range2065-2070
StatusPublished
Release year2009
Language in which the publication is writtenEnglish
DOI10.1002/art.24633
KeywordsHip Joint; RNA Small Interfering; Arthritis Rheumatoid; Humans; Prosthesis Failure; SUMO-1 Protein; Apoptosis; Knee Joint; Antigens CD95. Endopeptidases; Synovial Membrane; RNA Messenger; Gene Knockdown Techniques; Hip Joint; RNA Small Interfering; Arthritis Rheumatoid; Humans; Prosthesis Failure; SUMO-1 Protein; Apoptosis; Knee Joint; Antigens CD95. Endopeptidases; Synovial Membrane; RNA Messenger; Gene Knockdown Techniques

Authors from the University of Münster

Pap, Thomas
Institute of Musculoskeletal Medicine (IMM)
Strietholt, Simon
Institute of Musculoskeletal Medicine (IMM)